“Defining the molecular mechanisms linking STK11 loss with ineffectiveness of anti-PD1 therapy in KRAS-driven lung adenocarcinomas”

UVM Department of Medicine (Division of Hematology and Oncology) Grand Rounds Seminar
Online 8:00-9:00 AM – Join the seminar
“Defining the molecular mechanisms linking STK11 loss with ineffectiveness of anti-PD1 therapy in KRAS-driven lung adenocarcinomas”
David Seward, MD, PhD, Assistant Professor, Department of Pathology & Laboratory Medicine
University of Vermont